Verrica Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Verrica Pharmaceuticals Stock Summary

Verrica Pharmaceuticals competes with Inventiva, Edgewise Therapeutics, Vigil Neuroscience, Connect Biopharma, and Acumen Pharmaceuticals. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. Verrica Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.

Verrica Pharmaceuticals Key Financial Ratios

Verrica Pharmaceuticals Key Balance Sheet Accounts

Verrica Pharmaceuticals Key Income Statement Accounts

Verrica Pharmaceuticals Key Cash Accounts

Verrica Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Verrica Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Verrica Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Verrica Pharmaceuticals competition to find correlations between indicators driving Verrica Pharmaceuticals's intrinsic value. More Info.Verrica Pharmaceuticals is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Verrica Pharmaceuticals' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Verrica Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Verrica Pharmaceuticals Systematic Risk

Today, most investors in Verrica Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Verrica Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Verrica Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Verrica Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Verrica Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Verrica Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Verrica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Verrica Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.